Publication | Closed Access
Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma
63
Citations
45
References
2014
Year
Hematological MalignancyBone LossBone Morphogenic ProteinMedicinePim-2 KinaseTumor ProgressionTumor SuppressorRadiation OncologyOncologyCell BiologyTumor MicroenvironmentCancer ResearchCancer Growth
| Year | Citations | |
|---|---|---|
Page 1
Page 1